CIPH Ciphergen Biosystems (MM)

FREMONT, Calif., Feb. 14 /PRNewswire-FirstCall/ -- Ciphergen Biosystems (NASDAQ:CIPH) announces the following Webcast: What: 4th Quarter Year End Financial Results and Events When: Thursday, February 16, 2006 @ 5:00 p.m. EST Where: http://www.ciphergen.com/ How: Live over the Internet -- Simply log on to the web at the address above. If you are unable to participate during the live webcast, the call will be archived at http://www.ciphergen.com/ . To access the replay, click on investors button from our homepage. About Ciphergen Ciphergen is dedicated to the discovery of protein biomarkers and panels of biomarkers and their development into protein molecular diagnostic tests that improve patient care; and to providing collaborative R&D services through its Biomarker Discovery Center(R) laboratories for biomarker discovery for new diagnostic tests as well as pharmacoproteomic services for improved drug toxicology, efficacy and theranostic assays. Ciphergen develops, manufactures and markets a family of ProteinChip(R) Systems and services for clinical, research and process proteomics applications. ProteinChip Systems enable protein discovery, validation, identification and assay development to provide researchers with predictive, multi-marker assay capabilities and a better understanding of biological function at the protein level. Additional information about Ciphergen can be found at http://www.ciphergen.com/. DATASOURCE: Ciphergen Biosystems, Inc. CONTACT: Sue Carruthers of Ciphergen Biosystems, Inc., +1-510-673-9006 Web site: http://www.ciphergen.com/

Copyright